Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SARGRAMOSTIM vs SATRALIZUMAB-MWGE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SARGRAMOSTIM vs SATRALIZUMAB-MWGE: Safety Overview

Metric SARGRAMOSTIM SATRALIZUMAB-MWGE
Total FAERS Reports 593 1,112
Deaths Reported 85 54
Death Rate 14.3% 4.9%
Hospitalizations 138 398
Average Patient Age 34.4 yrs 56.3 yrs
% Female Patients 43.5% 86.4%
Manufacturer Partner Therapeutics, Inc. N/A
Route INTRAVENOUS N/A
Marketing Status Prescription N/A